Advertisement
Berita Valas
Ferrari Q4 Net Profit Rises 3%; Initiates FY23 Outlook
Italian luxury sports carmaker Ferrari N.V. (RACE) reported Thursday that its net profit for the fourth quarter increased to 221 million euros or 1.21 euros per share from 214 million euros or 1.16 euros per share in the prior-year quarter.
RTTNews |
1318 days ago
Bristol-Myers Squibb Guides FY23 Adj. EPS In Line; Q4 Results Top Estimates
While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) provided earnings, adjusted earnings and revenue guidance for the full-year 2023.
RTTNews
|
1318 days ago
Swiss Consumer Confidence Improves Sharply On Stronger Expectations
Consumer sentiment in Switzerland sharply improved in the January quarter to top economists' expectations, driven by significantly less pessimism among households' regarding their own and the national economic situation in the coming months, survey data from the State Secretariat For Economic Affairs, or SECO, showed Thursday. The consumer confidence index climbed to -30 from -47 in the October.
RTTNews
|
1318 days ago
Quest Diagnostics Guides FY23 Adj. EPS In Line With Estimates - Update
While reporting financial results for the fourth quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2023.
RTTNews
|
1318 days ago
Pound Rebounds After BoE Decision
As expected, the Bank of England raised its key rate by 50 basis points to 4 percent from 3.50 percent. Following the decision, the pound recovered against its major counterparts.
RTTNews
|
1318 days ago
Becton, Dickinson Boosts FY23 Outlook - Update
While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews
|
1318 days ago
Pound Falls Sharply Ahead Of BoE Decision
The Bank of England's monetary policy announcement is due at 7:00 am ET Thursday.The BoE is widely expected to raise its key rate by 50 basis points to 4 percent from 3.50 percent.
RTTNews
|
1318 days ago
more news
Spain Tourist Arrivals Rise 39.9%
Spain's visitor arrivals increased at a faster pace in December amid a recovery in domestic tourism from the pandemic related woes and due to the year-end holidays, data from the statistical office INE showed on Thursday. Tourist arrivals climbed 39.9 percent year-on-year after a 29.2 percent rise in November. For the full year 2022, arrivals increased 129.5 percent to 71.6 million.
RTTNews
|
1318 days ago
TIM Group Announces Non-binding Offer From KKR For Stake In Company
TIM Group (TIAOF.PK, TI) announced Thursday that it has received a non-binding offer from KKR & Co., Inc. (KKR) for the purchase of a stake in a company to be set up that matches with the fixed-line network management and infrastructure perimeter, including FiberCop's assets and activities, as well as the stake in Sparkle, known as Netco.
RTTNews
|
1318 days ago
Spain Unemployment Lowest In 15 Years
Spain reported a sharp growth in the number of jobless in January, reflecting the usual trend of rising unemployment at the start of the year, but the overall total of those without jobs was the lowest for the month since 2008. The number of registered unemployed increased by 70,744 persons from December, data from the labor ministry showed Thursday.
RTTNews
|
1318 days ago
Stanley Black & Decker Guides FY23 Above Estimates - Update
While reporting financial results for the fourth quarter on Thursday, Stanley Black & Decker (SWK) initiated its earnings and adjusted earnings outlook for the full-year 2023, above analysts' estimates.
RTTNews
|
1318 days ago
Sensex, Nifty End Volatile Session Mixed
Indian shares ended a highly volatile session mixed Thursday despite positive global cues.
RTTNews
|
1318 days ago
FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis
The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval.
RTTNews
|
1318 days ago
Stay up to date!
Tambahkan Berita ke browser Anda
Add To Chrome
